Eterna Therapeutics Inc (ERNA) — Cash Flow Reinvestment Rate
Eterna Therapeutics Inc (ERNA) has a Cash Flow Reinvestment Rate of 0.00x as of September 2019, reinvesting $0.00 (capex $0.00 ) from operating cash flow of $88.00 Million. See how much free cash does Eterna Therapeutics Inc generate to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Eterna Therapeutics Inc Cash Flow Reinvestment Rate (2009–2019)
Historical reinvestment intensity for Eterna Therapeutics Inc across 9 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Eterna Therapeutics Inc.
Annual Cash Flow Reinvestment Rate for Eterna Therapeutics Inc (2009–2019)
Year-by-year capital reinvestment analysis for Eterna Therapeutics Inc. See Eterna Therapeutics Inc free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2019 | 0.40x | $1.09 Million | $2.74 Million | $1.09 Million | ▼ -66.2% |
| 2018 | 1.18x | $1.61 Million | $1.36 Million | $1.61 Million | ▼ -55.3% |
| 2017 | 2.64x | $1.45 Million | $549.00K | $1.45 Million | ▼ -92.8% |
| 2016 | 36.52x | $840.00K | $23.00K | $840.00K | ▲ +6233.0% |
| 2013 | 0.58x | $861.00K | $1.49 Million | $861.00K | ▲ +1.4% |
| 2012 | 0.57x | $1.23 Million | $2.16 Million | $1.23 Million | ▼ -79.5% |
| 2011 | 2.78x | $1.59 Million | $574.00K | $1.59 Million | ▲ +494.2% |
| 2010 | 0.47x | $1.32 Million | $2.83 Million | $1.32 Million | ▼ -38.8% |
| 2009 | 0.76x | $1.91 Million | $2.50 Million | $1.91 Million | — |